Tarloxotinib (bromide), CAS 1636180-98-7

Tarloxotinib (bromide), CAS 1636180-98-7
SKU
MEXHY-17632-10.1
Packaging Unit
10 mM/1 ml
Manufacturer
MedChemExpress

Availability: loading...
Price is loading...
Product Description: Tarloxotinib bromide (TH-4000) is an irreversible EGFR/HER2 inhibitor.

Applications: Cancer-Kinase/protease

Formula: C24H24Br2ClN9O3

References: [1]Shevan Silva, Abstract A67: Preclinical efficacy of tarloxotinib bromide (TH-4000), a hypoxia-activated EGFR/HER2 inhibitor: rationale for clinical evaluation in EGFR mutant, T790M-negative NSCLC following progression on EGFR-TKI therapy. Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; November 5-9, 2015; Boston, MA./[2]Adam V. Patterson, Abstract 5358: The hypoxia-activated EGFR-TKI TH-4000 overcomes erlotinib-resistance in preclinical NSCLC models at plasma levels achieved in a Phase 1 clinical trial. AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA.

CAS Number: 1636180-98-7

Molecular Weight: 681.77

Compound Purity: 99.26

Research Area: Cancer

Solubility: DMSO : ≥ 33 mg/mL

Target: EGFR
More Information
SKU MEXHY-17632-10.1
Manufacturer MedChemExpress
Manufacturer SKU HY-17632-10.1
Package Unit 10 mM/1 ml
Quantity Unit STK
Product information (PDF) Download
MSDS (PDF) Download